Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: A study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG)

Radiotherapy and Oncology

Volumn 79, Issue 1, 2006, Pages 27-33

  Teo, Peter M L ^a   Leung, Sing Fai ^a   Tung, Stewart Y ^b   Zee, Benny ^a   Sham, Jonathan S T ^c   Lee, Anne W M ^d   Lau, Wai Hon ^e   Kwan, Wing Hong ^a   Leung, To Wai ^b   Chua, Daniel ^c   Sze, Wai Man ^d   Au, Joseph S K ^e   Yu, Kwok Hung ^a   O, Sai Ki ^b   Kwong, Dora ^c   Yau, Tsz Kok ^d   Law, Stephen C K ^e   Sze, Wing Kin ^b   Au, Gordon ^c   Chan, Anthony T C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b TUEN MUN HOSPITAL   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^e QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Dose response; Local control; Nasopharyngeal carcinoma

Indexed keywords

ADULT; AGE DISTRIBUTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; DATA ANALYSIS; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HAZARD ASSESSMENT; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION INJURY; RETROSPECTIVE STUDY; SEX DETERMINATION; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS; TREATMENT FAILURE; UNIVARIATE ANALYSIS;

ADULT; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; MEDICAL RECORDS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33747874526     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.03.012     Document Type: Article

References (32)

1. Al-Sarraf M., LeBlanc M., Giri P., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 16 (1998) 1310-1317
2. Butler E.B., Teh B.S., Grant W.H., et al. SMART (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 45 (1999) 21-32
3. Chan A.T.C., Teo P.M.L., Ngan R.K., et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomised trial. J Clin Oncol 20 (2002) 2038-2044
4. Chang S.D., Tate D.J., Goffinet D.R., et al. Treatment of nasopharyngeal carcinoma: stereotactic radiosurgical boost following fractionated radiotherapy. Stereotact Funct Neurosurg 73 (1999) 64-67
5. Chao K.S., Low D.A., Perez C.A., and Purdy J.A. Intensity-modulated radiation therapy in head and neck cancers: the mallinckrodt experience. Int J Cancer 90 (2000) 92-103
6. Cheng J.C., Chao K.S., and Low D. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer 96 (2001) 126-131
7. Cmelak A.J., Cox R.S., Adler J.R., et al. Radiosurgery for skull base malignancies and nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 37 (1997) 997-1003
8. Chua D.T., Nicholls J.M., Sham J.S., and Au G.K. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 59 (2004) 11-20
9. Eisbruch A., Schwartz M., Rasch C., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 60 (2004) 1425-1439
10. Ho J.H.C. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int Radiat Oncol Biol Phys 4 (1978) 183-198
11. Honore H.B., Bentzen S.M., Moller K., and Grau C. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation. Radiother Oncol 65 (2002) 9-16
12. Jen Y.M., Lin Y.S., Su W.F., et al. Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?. Int J Radiat Oncol Biol Phys 54 (2002) 14-22
13. Kam M.K.M., Teo P.M.L., Chau R.M.C., et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 60 (2004) 1440-1450
14. Kwong D.L.W., Nicholls J., Wei W.I., et al. The time course of histologic remission after treatment of patients with nasopharyngeal carcinoma. Cancer 85 (1999) 1446-1453
15. Lee A.W.M., Poon Y.F., Foo W., et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 23 (1992) 261-270
16. Lee N., Xia P., Quivery J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53 (2002) 12-22
17. Leung T.W., Tung S.Y., Sze W.K., et al. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma. Int Radiat Oncol Biol Phys 47 (2000) 405-412
18. Leung T.W., Tung S.Y., Wong V.Y., et al. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease. Cancer 104 (2005) 1648-1655
19. Leung T.W., Wong V.Y., Tung S.Y., et al. The importance of three-dimensional brachytherapy treatment planning for nasopharyngeal carcinoma. Clin Oncol 9 (1997) 35-40
20. Ozyar E., Gurkaynak M., Yildiz F., and Atahan I.L. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival. Radiother Oncol 72 (2004) 71-77
21. Sham J.S.T., and Choy D. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival. Head Neck 13 (1991) 298-310
22. Sultanem K., Shu H.K., Xia P., et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 48 (2000) 711-722
23. Tate D.J., Adler Jr. J.R., Chang S.D., et al. Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control. Int J Radiat Oncol Biol Phys 45 (1999) 915-921
24. Teo P., Leung S.F., Choi P., et al. Afterloading radiotherapy for local persistence of nasopharyngeal carcinoma. Br J Radiol 67 (1994) 181-185
25. Teo P.M.L., Leung S.F., Fowler J., et al. Improved local control for early T-stage nasopharyngeal carcinoma (NPC)-a tale of two hospitals. Radiother Oncol 57 (2000) 155-166
26. Teo P.M.L., Leung S.F., Lee W.Y., and Zee B. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose. Int J Radiat Oncol Biol Phys 46 (2000) 445-458
27. Teo P.M.L., Tsao S.Y., Shiu W., et al. A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong. Int Radiat Oncol Biol Phys 17 (1989) 515-530
28. Teo P.M.L., Yu P., Lee W.Y., et al. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 36 (1996) 291-304
29. Wolden S.L., Zelefsky M.J., Hunt M.A., et al. Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 49 (2001) 1229-1234
30. Willner J., Baier K., Pfreundner L., and Flentje M. Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma. Acta Oncologica 38 (1999) 1025-1030
31. Waldron J., Tin M.M., Keller A., et al. Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma. Radiother Oncol 68 (2003) 153-161
32. Xia P., Fu K.K., Wong G.W., et al. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48 (2000) 329-337